These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10742161)

  • 1. Orphan amyloid diseases.
    Nat Struct Biol; 2000 Apr; 7(4):259-60. PubMed ID: 10742161
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
    Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
    Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.
    Yazaki M; Liepnieks JJ; Kincaid JC; Benson MD
    Muscle Nerve; 2003 Oct; 28(4):438-42. PubMed ID: 14506715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of familial amyloidotic polyneuropathy.
    Saraiva MJ
    J Peripher Nerv Syst; 1996; 1(3):179-88. PubMed ID: 10970108
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of transthyretin amyloid disease by changing protein misfolding energetics.
    Hammarström P; Wiseman RL; Powers ET; Kelly JW
    Science; 2003 Jan; 299(5607):713-6. PubMed ID: 12560553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver transplantation in familial amyloid polyneuropathy].
    Manns MP; Schmidt H
    Internist (Berl); 1998 Aug; 39(8):877-8. PubMed ID: 9757397
    [No Abstract]   [Full Text] [Related]  

  • 7. Trans-suppression of misfolding in an amyloid disease.
    Hammarström P; Schneider F; Kelly JW
    Science; 2001 Sep; 293(5539):2459-62. PubMed ID: 11577236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiological variability and its cause of familial amyloid polyneuropathy].
    Ikeda S
    No To Shinkei; 1994 May; 46(5):433-41. PubMed ID: 8060682
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hereditary amyloid neuropathies].
    Adams D; Said G
    Ann Med Interne (Paris); 1995; 146(3):157-65. PubMed ID: 7653916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
    Ando Y
    Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications and results of liver transplant in type I familial amyloid polyneuropathy].
    Parrilla Paricio P
    Gastroenterol Hepatol; 1999 Feb; 22 Suppl 1():27-31. PubMed ID: 10085599
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families.
    Planté-Bordeneuve V; Carayol J; Ferreira A; Adams D; Clerget-Darpoux F; Misrahi M; Said G; Bonaïti-Pellié C
    J Med Genet; 2003 Nov; 40(11):e120. PubMed ID: 14627687
    [No Abstract]   [Full Text] [Related]  

  • 13. Transthyretin amyloidosis: a little history of hereditary amyloidosis.
    Benson MD
    Amyloid; 2017 Mar; 24(sup1):76-77. PubMed ID: 28434305
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
    Soares ML; Coelho T; Sousa A; Batalov S; Conceição I; Sales-Luís ML; Ritchie MD; Williams SM; Nievergelt CM; Schork NJ; Saraiva MJ; Buxbaum JN
    Hum Mol Genet; 2005 Feb; 14(4):543-53. PubMed ID: 15649951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative conformations of amyloidogenic proteins govern their behavior.
    Kelly JW
    Curr Opin Struct Biol; 1996 Feb; 6(1):11-7. PubMed ID: 8696966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå Sweden, June 1999.
    Ericzon BG; Holmgren G; Lundgren E; Suhr OB
    Amyloid; 2000 Jun; 7(2):145-7. PubMed ID: 10842720
    [No Abstract]   [Full Text] [Related]  

  • 17. Transgenic mouse model of familial amyloidotic polyneuropathy type I: its production, biological features, and usefulness.
    Yi S; Takahashi K; Araki S; Yamamura K
    Lab Anim Sci; 1995 Apr; 45(2):173-5. PubMed ID: 7603019
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal amyloid and variant transthyretins.
    Benson MD
    Am J Pathol; 1996 Feb; 148(2):351-4. PubMed ID: 8579096
    [No Abstract]   [Full Text] [Related]  

  • 20. Transgenic mouse model for human genetic diseases.
    Yamamura K; Tashiro F; Yi S; Wakasugi S; Araki S; Maeda S; Shimada K
    Mol Reprod Dev; 1993 Oct; 36(2):248-50. PubMed ID: 8257578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.